Report cover image

Global Gene Synthesis Software Market Analysis and Forecast 2026-2032

Publisher APO Research, Inc.
Published Jan 04, 2026
Length 209 Pages
SKU # APRC20823684

Description

The global Gene Synthesis Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Gene Synthesis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gene Synthesis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Asia-Pacific market for Gene Synthesis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gene Synthesis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Gene Synthesis Software include Eurofins Genomics, ATUM, Biotage, Bioneer Corporation, Eurogentec, GenScript, GENEWIZ, Integrated DNA Technologies and OriGene Technologies, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Gene Synthesis Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gene Synthesis Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Gene Synthesis Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gene Synthesis Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gene Synthesis Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Gene Synthesis Software revenue, projected growth trends, production technology, application and end-user industry.

Gene Synthesis Software Segment by Company

Eurofins Genomics
ATUM
Biotage
Bioneer Corporation
Eurogentec
GenScript
GENEWIZ
Integrated DNA Technologies
OriGene Technologies
Thermo Fisher Scientific
Bio Basic
Twist Bioscience
BioCat GmbH
ProteoGenix
Charles River
Biosearch Technologies
Beijing SBS Genetech
Eton Bioscience

Gene Synthesis Software Segment by Type

Solid Phase Synthesis
Chip-based DNA Synthesis
PCR-based Enzyme Synthesis

Gene Synthesis Software Segment by Application

Academic and Research Institutes
Biotech and Pharmaceutical
Diagnostic Laboratories
Others

Gene Synthesis Software Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Synthesis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Synthesis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Synthesis Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Gene Synthesis Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Gene Synthesis Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Synthesis Software revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

209 Pages
1 Market Overview
1.1 Product Definition
1.2 Gene Synthesis Software Market by Type
1.2.1 Global Gene Synthesis Software Market Size by Type, 2021 VS 2025 VS 2032
1.2.2 Solid Phase Synthesis
1.2.3 Chip-based DNA Synthesis
1.2.4 PCR-based Enzyme Synthesis
1.3 Gene Synthesis Software Market by Application
1.3.1 Global Gene Synthesis Software Market Size by Application, 2021 VS 2025 VS 2032
1.3.2 Academic and Research Institutes
1.3.3 Biotech and Pharmaceutical
1.3.4 Diagnostic Laboratories
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Gene Synthesis Software Market Dynamics
2.1 Gene Synthesis Software Industry Trends
2.2 Gene Synthesis Software Industry Drivers
2.3 Gene Synthesis Software Industry Opportunities and Challenges
2.4 Gene Synthesis Software Industry Restraints
3 Global Growth Perspective
3.1 Global Gene Synthesis Software Market Perspective (2021-2032)
3.2 Global Gene Synthesis Software Growth Trends by Region
3.2.1 Global Gene Synthesis Software Market Size by Region: 2021 VS 2025 VS 2032
3.2.2 Global Gene Synthesis Software Market Size by Region (2021-2026)
3.2.3 Global Gene Synthesis Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
4.1 Global Gene Synthesis Software Revenue by Players
4.1.1 Global Gene Synthesis Software Revenue by Players (2021-2026)
4.1.2 Global Gene Synthesis Software Revenue Market Share by Players (2021-2026)
4.1.3 Global Gene Synthesis Software Players Revenue Share Top 10 and Top 5 in 2025
4.2 Global Gene Synthesis Software Key Players Ranking, 2024 VS 2025 VS 2026
4.3 Global Gene Synthesis Software Key Players Headquarters & Area Served
4.4 Global Gene Synthesis Software Players, Product Type & Application
4.5 Global Gene Synthesis Software Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Gene Synthesis Software Market CR5 and HHI
4.6.3 2025 Gene Synthesis Software Tier 1, Tier 2, and Tier 3
5 Gene Synthesis Software Market Size by Type
5.1 Global Gene Synthesis Software Revenue by Type (2021 VS 2025 VS 2032)
5.2 Global Gene Synthesis Software Revenue by Type (2021-2032)
5.3 Global Gene Synthesis Software Revenue Market Share by Type (2021-2032)
6 Gene Synthesis Software Market Size by Application
6.1 Global Gene Synthesis Software Revenue by Application (2021 VS 2025 VS 2032)
6.2 Global Gene Synthesis Software Revenue by Application (2021-2032)
6.3 Global Gene Synthesis Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
7.1 Eurofins Genomics
7.1.1 Eurofins Genomics Company Information
7.1.2 Eurofins Genomics Business Overview
7.1.3 Eurofins Genomics Gene Synthesis Software Revenue and Gross Margin (2021-2026)
7.1.4 Eurofins Genomics Gene Synthesis Software Product Portfolio
7.1.5 Eurofins Genomics Recent Developments
7.2 ATUM
7.2.1 ATUM Company Information
7.2.2 ATUM Business Overview
7.2.3 ATUM Gene Synthesis Software Revenue and Gross Margin (2021-2026)
7.2.4 ATUM Gene Synthesis Software Product Portfolio
7.2.5 ATUM Recent Developments
7.3 Biotage
7.3.1 Biotage Company Information
7.3.2 Biotage Business Overview
7.3.3 Biotage Gene Synthesis Software Revenue and Gross Margin (2021-2026)
7.3.4 Biotage Gene Synthesis Software Product Portfolio
7.3.5 Biotage Recent Developments
7.4 Bioneer Corporation
7.4.1 Bioneer Corporation Company Information
7.4.2 Bioneer Corporation Business Overview
7.4.3 Bioneer Corporation Gene Synthesis Software Revenue and Gross Margin (2021-2026)
7.4.4 Bioneer Corporation Gene Synthesis Software Product Portfolio
7.4.5 Bioneer Corporation Recent Developments
7.5 Eurogentec
7.5.1 Eurogentec Company Information
7.5.2 Eurogentec Business Overview
7.5.3 Eurogentec Gene Synthesis Software Revenue and Gross Margin (2021-2026)
7.5.4 Eurogentec Gene Synthesis Software Product Portfolio
7.5.5 Eurogentec Recent Developments
7.6 GenScript
7.6.1 GenScript Company Information
7.6.2 GenScript Business Overview
7.6.3 GenScript Gene Synthesis Software Revenue and Gross Margin (2021-2026)
7.6.4 GenScript Gene Synthesis Software Product Portfolio
7.6.5 GenScript Recent Developments
7.7 GENEWIZ
7.7.1 GENEWIZ Company Information
7.7.2 GENEWIZ Business Overview
7.7.3 GENEWIZ Gene Synthesis Software Revenue and Gross Margin (2021-2026)
7.7.4 GENEWIZ Gene Synthesis Software Product Portfolio
7.7.5 GENEWIZ Recent Developments
7.8 Integrated DNA Technologies
7.8.1 Integrated DNA Technologies Company Information
7.8.2 Integrated DNA Technologies Business Overview
7.8.3 Integrated DNA Technologies Gene Synthesis Software Revenue and Gross Margin (2021-2026)
7.8.4 Integrated DNA Technologies Gene Synthesis Software Product Portfolio
7.8.5 Integrated DNA Technologies Recent Developments
7.9 OriGene Technologies
7.9.1 OriGene Technologies Company Information
7.9.2 OriGene Technologies Business Overview
7.9.3 OriGene Technologies Gene Synthesis Software Revenue and Gross Margin (2021-2026)
7.9.4 OriGene Technologies Gene Synthesis Software Product Portfolio
7.9.5 OriGene Technologies Recent Developments
7.10 Thermo Fisher Scientific
7.10.1 Thermo Fisher Scientific Company Information
7.10.2 Thermo Fisher Scientific Business Overview
7.10.3 Thermo Fisher Scientific Gene Synthesis Software Revenue and Gross Margin (2021-2026)
7.10.4 Thermo Fisher Scientific Gene Synthesis Software Product Portfolio
7.10.5 Thermo Fisher Scientific Recent Developments
7.11 Bio Basic
7.11.1 Bio Basic Company Information
7.11.2 Bio Basic Business Overview
7.11.3 Bio Basic Gene Synthesis Software Revenue and Gross Margin (2021-2026)
7.11.4 Bio Basic Gene Synthesis Software Product Portfolio
7.11.5 Bio Basic Recent Developments
7.12 Twist Bioscience
7.12.1 Twist Bioscience Company Information
7.12.2 Twist Bioscience Business Overview
7.12.3 Twist Bioscience Gene Synthesis Software Revenue and Gross Margin (2021-2026)
7.12.4 Twist Bioscience Gene Synthesis Software Product Portfolio
7.12.5 Twist Bioscience Recent Developments
7.13 BioCat GmbH
7.13.1 BioCat GmbH Company Information
7.13.2 BioCat GmbH Business Overview
7.13.3 BioCat GmbH Gene Synthesis Software Revenue and Gross Margin (2021-2026)
7.13.4 BioCat GmbH Gene Synthesis Software Product Portfolio
7.13.5 BioCat GmbH Recent Developments
7.14 ProteoGenix
7.14.1 ProteoGenix Company Information
7.14.2 ProteoGenix Business Overview
7.14.3 ProteoGenix Gene Synthesis Software Revenue and Gross Margin (2021-2026)
7.14.4 ProteoGenix Gene Synthesis Software Product Portfolio
7.14.5 ProteoGenix Recent Developments
7.15 Charles River
7.15.1 Charles River Company Information
7.15.2 Charles River Business Overview
7.15.3 Charles River Gene Synthesis Software Revenue and Gross Margin (2021-2026)
7.15.4 Charles River Gene Synthesis Software Product Portfolio
7.15.5 Charles River Recent Developments
7.16 Biosearch Technologies
7.16.1 Biosearch Technologies Company Information
7.16.2 Biosearch Technologies Business Overview
7.16.3 Biosearch Technologies Gene Synthesis Software Revenue and Gross Margin (2021-2026)
7.16.4 Biosearch Technologies Gene Synthesis Software Product Portfolio
7.16.5 Biosearch Technologies Recent Developments
7.17 Beijing SBS Genetech
7.17.1 Beijing SBS Genetech Company Information
7.17.2 Beijing SBS Genetech Business Overview
7.17.3 Beijing SBS Genetech Gene Synthesis Software Revenue and Gross Margin (2021-2026)
7.17.4 Beijing SBS Genetech Gene Synthesis Software Product Portfolio
7.17.5 Beijing SBS Genetech Recent Developments
7.18 Eton Bioscience
7.18.1 Eton Bioscience Company Information
7.18.2 Eton Bioscience Business Overview
7.18.3 Eton Bioscience Gene Synthesis Software Revenue and Gross Margin (2021-2026)
7.18.4 Eton Bioscience Gene Synthesis Software Product Portfolio
7.18.5 Eton Bioscience Recent Developments
8 North America
8.1 North America Gene Synthesis Software Revenue (2021-2032)
8.2 North America Gene Synthesis Software Revenue by Type (2021-2032)
8.2.1 North America Gene Synthesis Software Revenue by Type (2021-2026)
8.2.2 North America Gene Synthesis Software Revenue by Type (2027-2032)
8.3 North America Gene Synthesis Software Revenue Share by Type (2021-2032)
8.4 North America Gene Synthesis Software Revenue by Application (2021-2032)
8.4.1 North America Gene Synthesis Software Revenue by Application (2021-2026)
8.4.2 North America Gene Synthesis Software Revenue by Application (2027-2032)
8.5 North America Gene Synthesis Software Revenue Share by Application (2021-2032)
8.6 North America Gene Synthesis Software Revenue by Country
8.6.1 North America Gene Synthesis Software Revenue by Country (2021 VS 2025 VS 2032)
8.6.2 North America Gene Synthesis Software Revenue by Country (2021-2026)
8.6.3 North America Gene Synthesis Software Revenue by Country (2027-2032)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Gene Synthesis Software Revenue (2021-2032)
9.2 Europe Gene Synthesis Software Revenue by Type (2021-2032)
9.2.1 Europe Gene Synthesis Software Revenue by Type (2021-2026)
9.2.2 Europe Gene Synthesis Software Revenue by Type (2027-2032)
9.3 Europe Gene Synthesis Software Revenue Share by Type (2021-2032)
9.4 Europe Gene Synthesis Software Revenue by Application (2021-2032)
9.4.1 Europe Gene Synthesis Software Revenue by Application (2021-2026)
9.4.2 Europe Gene Synthesis Software Revenue by Application (2027-2032)
9.5 Europe Gene Synthesis Software Revenue Share by Application (2021-2032)
9.6 Europe Gene Synthesis Software Revenue by Country
9.6.1 Europe Gene Synthesis Software Revenue by Country (2021 VS 2025 VS 2032)
9.6.2 Europe Gene Synthesis Software Revenue by Country (2021-2026)
9.6.3 Europe Gene Synthesis Software Revenue by Country (2027-2032)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Gene Synthesis Software Revenue (2021-2032)
10.2 China Gene Synthesis Software Revenue by Type (2021-2032)
10.2.1 China Gene Synthesis Software Revenue by Type (2021-2026)
10.2.2 China Gene Synthesis Software Revenue by Type (2027-2032)
10.3 China Gene Synthesis Software Revenue Share by Type (2021-2032)
10.4 China Gene Synthesis Software Revenue by Application (2021-2032)
10.4.1 China Gene Synthesis Software Revenue by Application (2021-2026)
10.4.2 China Gene Synthesis Software Revenue by Application (2027-2032)
10.5 China Gene Synthesis Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
11.1 Asia Gene Synthesis Software Revenue (2021-2032)
11.2 Asia Gene Synthesis Software Revenue by Type (2021-2032)
11.2.1 Asia Gene Synthesis Software Revenue by Type (2021-2026)
11.2.2 Asia Gene Synthesis Software Revenue by Type (2027-2032)
11.3 Asia Gene Synthesis Software Revenue Share by Type (2021-2032)
11.4 Asia Gene Synthesis Software Revenue by Application (2021-2032)
11.4.1 Asia Gene Synthesis Software Revenue by Application (2021-2026)
11.4.2 Asia Gene Synthesis Software Revenue by Application (2027-2032)
11.5 Asia Gene Synthesis Software Revenue Share by Application (2021-2032)
11.6 Asia Gene Synthesis Software Revenue by Country
11.6.1 Asia Gene Synthesis Software Revenue by Country (2021 VS 2025 VS 2032)
11.6.2 Asia Gene Synthesis Software Revenue by Country (2021-2026)
11.6.3 Asia Gene Synthesis Software Revenue by Country (2027-2032)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Gene Synthesis Software Revenue (2021-2032)
12.2 SAMEA Gene Synthesis Software Revenue by Type (2021-2032)
12.2.1 SAMEA Gene Synthesis Software Revenue by Type (2021-2026)
12.2.2 SAMEA Gene Synthesis Software Revenue by Type (2027-2032)
12.3 SAMEA Gene Synthesis Software Revenue Share by Type (2021-2032)
12.4 SAMEA Gene Synthesis Software Revenue by Application (2021-2032)
12.4.1 SAMEA Gene Synthesis Software Revenue by Application (2021-2026)
12.4.2 SAMEA Gene Synthesis Software Revenue by Application (2027-2032)
12.5 SAMEA Gene Synthesis Software Revenue Share by Application (2021-2032)
12.6 SAMEA Gene Synthesis Software Revenue by Country
12.6.1 SAMEA Gene Synthesis Software Revenue by Country (2021 VS 2025 VS 2032)
12.6.2 SAMEA Gene Synthesis Software Revenue by Country (2021-2026)
12.6.3 SAMEA Gene Synthesis Software Revenue by Country (2027-2032)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.